Illumina (ILMN)
(Real Time Quote from BATS)
$153.69 USD
+3.93 (2.62%)
Updated Nov 4, 2024 03:55 PM ET
After-Market: $144.18 -9.51 (-6.19%) 4:16 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$153.69 USD
+3.93 (2.62%)
Updated Nov 4, 2024 03:55 PM ET
After-Market: $144.18 -9.51 (-6.19%) 4:16 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Zacks News
Illumina (ILMN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed the most recent trading day at $300.91, moving +1.14% from the previous trading session.
Illumina Banks on New Product Suite Despite Margin Woes
by Zacks Equity Research
The unveiling of Veriseq NIPT v2 and Illumina's (ILMN) alliance with AnchorDx in the second quarter further raise investor confidence in the stock.
Probability 101: How Not to Be a Sucker
by Kevin Cook
We need science and math -- and STEM-savvy minds -- more than ever to help us inform decision making.
Illumina (ILMN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Illumina (ILMN) closed at $271.71, marking a -0.17% move from the previous day.
ETFs to Gain From the Booming Genomics Market
by Sweta Jaiswal, FRM
Rising investments, surging demand for personalized medicines and shrinking sequencing costs are a slew of factors favouring the genomics space. We look at a few ETFs that can cash in on this trend.
Top-Performing Biotech ETFs YTD
by Sweta Jaiswal, FRM
Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to boost the biotech stocks. Accordingly, we take a look at biotech ETFs gaining more than 10% year to date.
Illumina (ILMN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed at $281.62 in the latest trading session, marking a -1.19% move from the prior day.
Why Is Illumina (ILMN) Down 5% Since Last Earnings Report?
by Zacks Equity Research
Illumina (ILMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Illumina (ILMN) Q2 Earnings Beat Estimates, Margins Contract
by Zacks Equity Research
Illumina's (ILMN) witnessed top-line growth across its high and low throughput categories in the second quarter of 2019.
Illumina (ILMN) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Illumina (ILMN) delivered earnings and revenue surprises of 2.27% and 0.33%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Illumina, GW Pharmaceuticals, Paycom, Zscaler and Square highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Illumina, GW Pharmaceuticals, Paycom, Zscaler and Square highlighted as Zacks Bull and Bear of the Day
What to Expect from Illumina Earnings After Preliminary Results Tanked ILMN Stock
by Zachary Stutler
Illumina is set to report its Q2 earnings on Monday, July 29 and investors are waiting to see if there is anything that might help the stock recover from its recent fall.
Bear of the Day: Illumina (ILMN)
by Kevin Cook
The NASA of biotech just hit a growth speed-bump on its way to helping the world explore ancestry and disease
Can Sequencing Products Drive Illumina's (ILMN) Q2 Earnings?
by Zacks Equity Research
Illumina (ILMN) is expected to deliver a strong second quarter on impressive performance by sequencing portfolio.
Illumina (ILMN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Illumina (ILMN) closed at $298.28, marking a +1.73% move from the previous day.
Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EXEL or ILMN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EXEL vs. ILMN: Which Stock Is the Better Value Option?
Illumina (ILMN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed the most recent trading day at $302.29, moving -0.9% from the previous trading session.
Company News for Jul 15, 2019
by Zacks Equity Research
Companies In The News Are: ILMN,MCRN,HI,JNJ,ACN
Illumina (ILMN) Grows on Innovation & International Growth
by Zacks Equity Research
Illumina (ILMN) is benefiting from sturdy demand for sequencing and array systems as well as consumables and services.
Illumina (ILMN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed at $377.24 in the latest trading session, marking a +0.57% move from the prior day.
Illumina (ILMN) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Illumina (ILMN) gains from expansion of its product portfolio and strategic partnership.
Illumina (ILMN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed the most recent trading day at $377.82, moving +1.74% from the previous trading session.
Five Runaway Breakout Stocks to Buy
by David Bartosiak
With the market at all-time highs again, the rich get richer as stocks continue to breakout.
Illumina (ILMN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Illumina (ILMN) closed at $358.08 in the latest trading session, marking a +0.1% move from the prior day.